Who Buys Exemestane from India — 196 Importers Behind a $14.5M Market
India's exemestane import market is served by 196 active buyers who collectively imported $14.5M across 1,533 shipments. CARDINAL HEALTH (UNITED STATES) leads with a 7.5% market share, followed by AUROBINDO PHARMA USA., INC, and BROCACEF NL HUB. The top 5 buyers together control 25.4% of total import value, reflecting a moderately competitive buyer landscape.
Top Exemestane Importers — Ranked by Import Value
CARDINAL HEALTH (UNITED STATES) is the leading exemestane importer from India, holding a 7.5% share of the $14.5M market across 1,533 shipments from 196 buyers. The top 5 buyers — CARDINAL HEALTH (UNITED STATES), AUROBINDO PHARMA USA., INC, (UNITED STATES), BROCACEF NL HUB (NETHERLANDS), FIEGE HEALTHCARE LOGISTICS GMBH (GERMANY), CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) — collectively control 25.4% of total import value.
Top Exemestane Buyers & Importers
Ranked by import value · 196 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | CARDINAL HEALTHUNITED STATES EXEMESTANE TABLETS 25 MG - 1 X 30.EXEMESTANE TABLETS 25 MGEXEMESTANE TABLETS 25 MG (EXEMESTANE TAB | $1.1M | 5 | 7.5% |
| 2 | AUROBINDO PHARMA USA., INC,UNITED STATES EXEMESTANE TABLETS 25 MG - 1 X 30.EXEMESTANE TABLETS 25 MGEXEMESTANE TABLETS 25 MG (EXEMESTANE TAB | $709.8K | 5 | 4.9% |
| 3 | BROCACEF NL HUBNETHERLANDS PHARMA DRUGS & MEDI EXEMESTANE 25MG 10X1PHARMA DRUG&MED:EXEMESTANE 25MG 10X10T G | $699.9K | 5 | 4.8% |
| 4 | FIEGE HEALTHCARE LOGISTICS GMBHGERMANY | $604.5K | 5 | 4.2% |
| 5 | CIPLA USA INC UPS SUPPLY CHAIN SOLUUNITED STATES EXEMESTANE TABLETS 25 MG - 1 X 30.EXEMESTANE TABLETS 25 MGEXEMESTANE TABLETS 25 MG (EXEMESTANE TAB | $586.8K | 5 | 4.1% |
| 6 | XXDUSXXHARXXCEUXXCALXXUSAXXNCUNITED STATES EXEMESTANE TABLETS 25 MG - 1 X 30.EXEMESTANE TABLETS 25 MGEXEMESTANE TABLETS 25 MG (EXEMESTANE TAB | $582.2K | 5 | 4.0% |
| 7 | AUROBINDO PHARMA USA INCUNITED STATES EXEMESTANE TABLETS 25 MG - 1 X 30.EXEMESTANE TABLETS 25 MGEXEMESTANE TABLETS 25 MG (EXEMESTANE TAB | $524.4K | 5 | 3.6% |
| 8 | ZYDUS PHARMACEUTICALS USA INCUNITED STATES EXEMESTANE TABLETS 25 MG - 1 X 30.EXEMESTANE TABLETS 25 MGEXEMESTANE TABLETS 25 MG (EXEMESTANE TAB | $443.3K | 5 | 3.1% |
| 9 | AUROBINDO PHARMA USA., INCUNITED STATES EXEMESTANE TABLETS 25 MG - 1 X 30.EXEMESTANE TABLETS 25 MGEXEMESTANE TABLETS 25 MG (EXEMESTANE TAB | $428.6K | 5 | 3.0% |
| 10 | M P LUNITED KINGDOM EXEMESTANE TABLETS 25 MG - 1 X 30.EXEMESTANE TABLETS 25 MGEXEMESTANE TABLETS 25MG ,BAT | $415.9K | 5 | 2.9% |
| 11 | EUROPEAN PHARMAHUBHUNGARY PH.DRU. & MED.: EXEMESTANE 25MG TABLETSPHR DRUGS&MEDI EXEMESTANE 25MG EACH TABL | $338.4K | 5 | 2.3% |
| 12 | ALTERNAVIDA SA DEMEXICO EXEMESTANE TABLETS USP 25MG PACK SIZE: 1X 30SEXEMESTANE TABLETS USP 25MGEXEMESTANE TAB 25MG 9X10B MX PACK : 09*1 | $309.4K | 5 | 2.1% |
| 13 | ACCORD UKUNITED KINGDOM EXEMESTANE TABLETS 25MG ,BATEXEMESTANE TABLETS 25MG EXEMESTANE PACK:3X10EXEMESTANE 25MG FILM COATED TABLETS | $281.6K | 5 | 1.9% |
| 14 | SUN FARMACUTICA DO BRASIL LTDA,BRAZIL EXEMESTANE TABLETS 25MG ,BATEXEMESTANE TABLETS 25MG EXEMESTANE PACK:3X10EXEMESTANE TABLETS 25MG BN- | $276.7K | 5 | 1.9% |
| 15 | AUROLOGISTICS LLC, (AUROBINDO PHARMUNITED STATES EXEMESTANE TABLETS 25 MG - 1 X 30.EXEMESTANE TABLETS 25 MGEXEMESTANE TABLETS 25 MG (EXEMESTANE TAB | $255.5K | 5 | 1.8% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Exemestane — and from which countries?
Flow of Exemestane exports from India: each country's share and the named importers behind the numbers
Exemestane — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $5.7M through 60 shipments. This represents a market share of 39.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• CARDINAL HEALTH - $1.1M (19.0% of country's total business)
• AUROBINDO PHARMA USA., INC, - $709.8K (12.5% of country's total business)
• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $586.8K (10.3% of country's total business)
• XXDUSXXHARXXCEUXXCALXXUSAXXNC - $582.2K (10.2% of country's total business)
• AUROBINDO PHARMA USA INC - $524.4K (9.2% of country's total business)
• Rest of United States's importers - $2.2M (38.7% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $94.8K, indicating premium pricing strategy compared to the market average of $9.4K.
United States is a key market for Exemestane imports, representing 39.3% of total trade value.
2Brazil
Brazil emerges as the second largest importing country, achieving a total trade value of $1.8M through 2 shipments. This represents a market share of 12.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• SUN FARMACUTICA DO BRASIL LTDA, - $276.7K (15.6% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $884.2K, indicating premium pricing strategy compared to the market average of $9.4K.
Brazil is a key market for Exemestane imports, representing 12.2% of total trade value.
3Netherlands
Netherlands emerges as the third largest importing country, achieving a total trade value of $1.7M through 20 shipments. This represents a market share of 11.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• BROCACEF NL HUB - $699.9K (41.3% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $84.7K, indicating premium pricing strategy compared to the market average of $9.4K.
Netherlands is a key market for Exemestane imports, representing 11.7% of total trade value.
4United Kingdom
United Kingdom emerges as the fourth largest importing country, achieving a total trade value of $1.4M through 11 shipments. This represents a market share of 9.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• M P L - $415.9K (29.6% of country's total business)
• ACCORD UK - $281.6K (20.0% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $127.7K, indicating premium pricing strategy compared to the market average of $9.4K.
United Kingdom is a key market for Exemestane imports, representing 9.7% of total trade value.
5Germany
Germany emerges as the fifth largest importing country, achieving a total trade value of $882.2K through 19 shipments. This represents a market share of 6.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• FIEGE HEALTHCARE LOGISTICS GMBH - $604.5K (68.5% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $46.4K, indicating premium pricing strategy compared to the market average of $9.4K.
Germany is a key market for Exemestane imports, representing 6.1% of total trade value.
Buyer Segment Analysis
TransData Nexus Exemestane buyer market intelligence
1Buyer Segment Analysis
The 196 buyers of Exemestane from India can be categorized into several segments:
1. Distributors: Entities like Cardinal Health (United States, $1.08M) and Brocacef NL Hub (Netherlands, $0.70M) fall into this category. These organizations purchase large quantities to supply pharmacies, hospitals, and clinics. Their buying behavior typically involves bulk orders to leverage economies of scale, with a focus on maintaining a consistent supply chain to meet market demand.
2. Pharmaceutical Companies: Companies such as Aurobindo Pharma USA, Inc. (United States, $0.71M) and Cipla USA Inc. (United States, $0.59M) import Exemestane for further distribution or inclusion in their product portfolios. Their procurement patterns are influenced by market demand forecasts, regulatory approvals, and competitive positioning.
3. Logistics and Healthcare Service Providers: Organizations like Fiege Healthcare Logistics GmbH (Germany, $0.60M) specialize in the storage and distribution of pharmaceuticals. They procure Exemestane to fulfill contracts with healthcare providers, ensuring timely delivery and compliance with storage requirements.
4. Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, these entities procure Exemestane to meet patient needs. Their purchasing decisions are driven by treatment protocols, patient demographics, and formulary inclusions.
5. Re-exporters: Some buyers may act as intermediaries, importing Exemestane for re-export to other markets. Their procurement is influenced by global demand trends and trade regulations.
6. Government Procurement Agencies: Entities involved in national tenders or international health programs may also be buyers, focusing on bulk purchases to supply public health facilities. Their buying behavior is characterized by adherence to tender specifications, pricing negotiations, and compliance with regulatory standards.
Country-Specific Import Regulations
TransData Nexus Exemestane buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Exemestane are as follows:
1. United States:
2. Brazil:
3. Netherlands:
4. United Kingdom:
5. Germany:
Demand Drivers & Market Opportunity
TransData Nexus Exemestane buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Exemestane in importing countries is primarily driven by the prevalence of hormone receptor-positive breast cancer, for which Exemestane is a standard treatment. According to the World Health Organization (WHO), breast cancer remains the most common cancer among women worldwide, with approximately 2.3 million new cases diagnosed in 2025. Government healthcare programs and the expansion of universal health coverage have increased access to cancer treatments, further driving demand.
Additionally, Exemestane's inclusion in the WHO Model List of Essential Medicines underscores its importance in cancer treatment protocols. This inclusion facilitates procurement through international health programs and tender-based purchasing, ensuring broader accessibility. The presence of 196 buyers across 57 countries, as per TransData Nexus data, indicates a robust and diverse market for Exemestane, presenting significant opportunities for suppliers to meet the global demand for this essential medication.
Common Questions — Exemestane Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest exemestane buyer importing from India?
Based on import volume and value, CARDINAL HEALTH (UNITED STATES) leads with $1.1M in imports and a 7.5% market share — the highest of any single exemestane importer. AUROBINDO PHARMA USA., INC, (UNITED STATES) and BROCACEF NL HUB (NETHERLANDS) are the next largest buyers.
QHow many companies buy exemestane from India?
There are 196 active exemestane buyers importing from India, with a combined market of $14.5M across 1,533 shipments to 57 countries. The top 5 buyers hold 25.4% of total import value, while the remaining 191 buyers handle the other 74.6%.
QWhich countries import the most exemestane from India?
The top importing countries for exemestane from India are United States (39.3%), Brazil (12.2%), Netherlands (11.7%), United Kingdom (9.7%), Germany (6.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of exemestane, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for exemestane from India?
The average import transaction value for exemestane from India is $9.4K, with an average unit price of $47.52 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Exemestane buyer market intelligence
1Buyer Segment Analysis
The 196 buyers of Exemestane from India can be categorized into several segments:
1. Distributors: Entities like Cardinal Health (United States, $1.08M) and Brocacef NL Hub (Netherlands, $0.70M) fall into this category. These organizations purchase large quantities to supply pharmacies, hospitals, and clinics. Their buying behavior typically involves bulk orders to leverage economies of scale, with a focus on maintaining a consistent supply chain to meet market demand.
2. Pharmaceutical Companies: Companies such as Aurobindo Pharma USA, Inc. (United States, $0.71M) and Cipla USA Inc. (United States, $0.59M) import Exemestane for further distribution or inclusion in their product portfolios. Their procurement patterns are influenced by market demand forecasts, regulatory approvals, and competitive positioning.
3. Logistics and Healthcare Service Providers: Organizations like Fiege Healthcare Logistics GmbH (Germany, $0.60M) specialize in the storage and distribution of pharmaceuticals. They procure Exemestane to fulfill contracts with healthcare providers, ensuring timely delivery and compliance with storage requirements.
4. Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, these entities procure Exemestane to meet patient needs. Their purchasing decisions are driven by treatment protocols, patient demographics, and formulary inclusions.
5. Re-exporters: Some buyers may act as intermediaries, importing Exemestane for re-export to other markets. Their procurement is influenced by global demand trends and trade regulations.
6. Government Procurement Agencies: Entities involved in national tenders or international health programs may also be buyers, focusing on bulk purchases to supply public health facilities. Their buying behavior is characterized by adherence to tender specifications, pricing negotiations, and compliance with regulatory standards.
Country-Specific Import Regulations
TransData Nexus Exemestane buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Exemestane are as follows:
1. United States:
2. Brazil:
3. Netherlands:
4. United Kingdom:
5. Germany:
Demand Drivers & Market Opportunity
TransData Nexus Exemestane buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Exemestane in importing countries is primarily driven by the prevalence of hormone receptor-positive breast cancer, for which Exemestane is a standard treatment. According to the World Health Organization (WHO), breast cancer remains the most common cancer among women worldwide, with approximately 2.3 million new cases diagnosed in 2025. Government healthcare programs and the expansion of universal health coverage have increased access to cancer treatments, further driving demand.
Additionally, Exemestane's inclusion in the WHO Model List of Essential Medicines underscores its importance in cancer treatment protocols. This inclusion facilitates procurement through international health programs and tender-based purchasing, ensuring broader accessibility. The presence of 196 buyers across 57 countries, as per TransData Nexus data, indicates a robust and diverse market for Exemestane, presenting significant opportunities for suppliers to meet the global demand for this essential medication.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 196 global importers of Exemestane identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 1,533 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 57 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,533 Verified Shipments
196 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists